Keya Medical will participate in the North American Society for Cardiovascular Imaging Annual Meeting, taking place September 26–29, 2026, at The Westin Denver Downtown in Colorado.

NASCI 2026 brings together radiologists, cardiologists, and other cardiovascular imaging professionals to explore advances in cardiac CT, MR, artificial intelligence, CT-derived fractional flow reserve, and other emerging technologies.

At the meeting, Keya Medical will showcase its two FDA-cleared CCTA analysis products:

DEEPVESSEL FFR provides noninvasive physiological assessment of the coronary arteries from CCTA images.

DEEPVESSEL Plaque provides quantitative analysis and visualization of coronary plaque.

Together, these complementary products support a more comprehensive assessment of coronary artery disease by combining physiological and anatomical information from CCTA images.

We look forward to meeting cardiovascular imaging professionals in Denver and discussing how Keya Medical’s AI-enabled technology can support clinical workflows and patient care.

Event details

NASCI 2026 Annual Meeting
September 26–29, 2026
The Westin Denver Downtown, Colorado

Interested in integration of AI-based FFR-CT and plaque analysis into your workflow?

Contact our team to learn more or schedule a demo.
e3c5e4a47744e5b9a4fa40908bd0e14e-us10